Giants Sanofi and GSK join forces to create coronavirus vaccine
The drugmakers plan to start human trials in the second half of 2020, and may have a vaccine available by the second half of 2021
London — Two of the world’s biggest vaccine makers are joining forces to tackle the coronavirus as the number of confirmed infections approaches 2-million worldwide.
Sanofi will test its experimental coronavirus vaccine with GlaxoSmithKline (GSK) supplying adjuvants, which are additional ingredients that improve efficacy and make it easier to produce shots in larger quantities, the companies said on Tuesday. The drugmakers said they plan to start human trials in the second half of this year, with the goal of having a vaccine available by the second half of 2021 if the studies are successful...